Walmart join MediLedger medical supply chain blockchain network

pharmafile | June 3, 2019 | News story | Manufacturing and Production |  MediLedger, blockchain, medical supply chain, pharma 

Walmart has joined the MediLedger network – a network of pharma firms who use a permissioned blockchain to manage the distribution of medical supplies.

The retail giant, who already use IBM’s blockchain network FoodTrust, has now joined the permissioned blockchain network MediLedger, whose members include Genentech, Pfizer and Gilead.

Walmart will use the MediLedger blockchain to improve their business selling healthcare products and medical supplies, a section of their business which accounted for $35 billion in revenue in the last financial year.

Advertisement

Based on Ethereum the MediLedger blockchain keeps an unchangeable record of transactions on a permissioned ledger.

MediLedger itself has set the bar high as it aims to create “an industry-wide network owned by the industry itself, connecting you to all your suppliers and customers.” The project was started in 2017.

Louis Goss

Related Content

Pharma sees climate disruption as growing supply-chain risk

Nine in ten pharmaceutical companies across the UK and G7 countries expect climate-related disruption to …

AI in pharma: From lab development to patient impact

In the decade to 2025, AI use in vaccine development has increased markedly but is …

drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

The Gateway to Local Adoption Series

Latest content